PREDICT scores and the expected breast cancer-associated mortality were calculated according to algorithm v 2.2., including variables for diagnosis age, tumor grade and size, lymph node and HER2 status, adjuvant therapy, and further adjusted for progesterone receptor expression2,9,24,25. Here, ERBB2 is linked to breast carcinoma.